PDI deal deploys 300 sales reps

Share this article:
PDI signed a deal with an undisclosed major pharmaceutical company to employ 300 sales reps and is expected to reap $35–$40 million, the contract sales force provider said.

The contract followed the April termination of the firm's agreement with AstraZeneca, which affected approximately 800 field reps and had a projected $60–$70 million impact.

“This particular ‘major pharmaceutical company' was not necessarily in the market for additional representatives but when they saw the fact that we had some reps trained in a specific category, the light bulb went off and they thought, ‘hey, we could use those people,'” said Stephen Cotugno, PDI EVP of corporate development.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Star Group merges with Vox Medica, Calcium NYC

Star Group merges with Vox Medica, Calcium NYC

The newly formed group will be known as Calcium with Steve Michaelson, formerly of Rosetta Wishbone, at the helm.

Survey finds pay doesn't make doctors happy

Survey finds pay doesn't make doctors happy

Medscape's survey of over 24,000 physicians found that a paycheck is not necessarily linked to a physician's professional satisfaction.

CDC sees declines in some diabetes complications

CDC sees declines in some diabetes complications

Centers for Disease Control data shows that diabetes complications including heart attack and amputation fell in the twenty years between 1990 and 2010. The bad news: the number of diagnosed ...